DHARA SHAH: Open Payments
NPI 1194475442 · SMITHFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 83 payments from 14 companies in 2025. Trend: 2023 $1,943 · 2024 $1,355 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $343 |
| ABBVIE INC. | 16 | $305 |
| PFIZER INC. | 14 | $263 |
| Novo Nordisk Inc | 9 | $203 |
| GlaxoSmithKline, LLC. | 12 | $194 |
| Exact Sciences Corporation | 4 | $97 |
| Verona Pharma, Inc. | 4 | $87 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, FARXIGA, TRELEGY ELLIPTA, ELIQUIS, NURTEC ODT, BREZTRI, AIRSUPRA, Ohtuvayre.
Industry payments across RI — which companies pay providers there.
